Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye

NCT00037661 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

222

Enrollment

INDUSTRY

Sponsor class

Conditions

Keratoconjunctivitis Sicca

Interventions

DRUG: INS365 Ophthalmic Solution

Sponsor

Merck Sharp & Dohme LLC